IOVA · Mid Cap · Healthcare · Biotechnology
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
63/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Lowest
$7
Current price
$14.16
Median target
$15.5
Highest
$20
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Debt / equity
Favorable · 0.06 - strong leverage
0.06x
Current ratio
Strong · Good liquidity position
4.35x
Price / sales
Rich · Overpriced by revenue
18.98x
ROIC
Weak · Weak capital efficiency
-24.1%
ROE
Needs attention · Unfavorable
-40.4%
IOVA against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $6.17B | - | +34.5% | 63 | |
| $10.30B | 19.6 | +19.7% | 78 | |
| $32.47B | 34.0 | +15.5% | 78 | |
| $3.83B | 11.5 | +13.5% | 78 | |
| $1.18T | 42.7 | +49.6% | 77 |